{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:39:43Z","timestamp":1786721983020,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijid.2020.02.034","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T11:39:38Z","timestamp":1582803578000},"page":"S37-S40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"S","title":["Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries"],"prefix":"10.1016","volume":"92","author":[{"given":"Xiaojing","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9957-4527","authenticated-orcid":false,"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.02.034_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047769","article-title":"Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis","volume":"7","author":"Cai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2020.02.034_bib0010","first-page":"121","article-title":"Comparison and analysis of TST and IGRAs for testing tuberculosis infection of health care workers","volume":"2","author":"Di","year":"2014","journal-title":"Chin J Antitubercul"},{"issue":"3","key":"10.1016\/j.ijid.2020.02.034_bib0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(14)71085-0","article-title":"Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study","volume":"15","author":"Gao","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.02.034_bib0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1183\/13993003.00235-2016","article-title":"Annual risk of tuberculosis infection in rural China: a population-based prospective study","volume":"48","author":"Gao","year":"2016","journal-title":"Eur Respir J"},{"issue":"October (10)","key":"10.1016\/j.ijid.2020.02.034_bib0025","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1473-3099(17)30402-4","article-title":"Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicenter, prospective cohort study","volume":"17","author":"Gao","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"December (6)","key":"10.1016\/j.ijid.2020.02.034_bib0030","article-title":"Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomized controlled study","volume":"52","author":"Gao","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2020.02.034_bib0035","series-title":"Code of practice for prevention and control of tuberculosis in schools","author":"General Office of National Health and Family Planning Commission","year":"2017"},{"key":"10.1016\/j.ijid.2020.02.034_bib0040","unstructured":"Geneva: World Health Organization. Global Tuberculosis Report 2019."},{"issue":"November (11)","key":"10.1016\/j.ijid.2020.02.034_bib0045","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1111\/crj.12960","article-title":"First assessment of interferon gamma release assay results among healthcare workers at a general hospital in China","volume":"12","author":"Guo","year":"2018","journal-title":"Clin Respir J"},{"issue":"8","key":"10.1016\/j.ijid.2020.02.034_bib0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2471\/BLT.18.218651","article-title":"Prevention of tuberculosis in household members: estimates of children eligible for treatment","volume":"97","author":"Hamada","year":"2019","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.ijid.2020.02.034_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ijid.2020.02.034_bib0060","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jinf.2012.03.018","article-title":"Use of the T-SPOT.TB assay to screen latent tuberculosis infection among the TB contacts in Shanghai, China","volume":"65","author":"Hu","year":"2012","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.ijid.2020.02.034_bib0065","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/eurpub\/ckt105","article-title":"Prevalence of latent tuberculosis infection and its risk factors in schoolchildren and adolescents in Shanghai, China","volume":"23","author":"Hu","year":"2013","journal-title":"Eur J Public Health"},{"issue":"4","key":"10.1016\/j.ijid.2020.02.034_bib0070","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s11684-017-0573-0","article-title":"Testing of tuberculosis infection among Chinese adolescents born after terminating the Bacillus Calmette-Gu\u00e9rin booster vaccination: subgroup analysis of a population-based cross-sectional study","volume":"11","author":"Li","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.ijid.2020.02.034_bib0075","first-page":"139","article-title":"Control in university students in Beijing: preventive therapy for tuberculosis-infected persons","volume":"3","author":"Liu","year":"2005","journal-title":"Chin J Antitubercul"},{"issue":"1","key":"10.1016\/j.ijid.2020.02.034_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/17425255.2018.1416093","article-title":"Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?","volume":"14","author":"Motta","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"10.1016\/j.ijid.2020.02.034_bib0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)30436-2","article-title":"Safety and efficacy of the C-Tb skin test to diagnose, Mycobacterium tuberculosis, infection, compared with an interferon \u03b3 release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial","volume":"5","author":"Ruhwald","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.ijid.2020.02.034_bib0090","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.5588\/ijtld.19.0018","article-title":"Policies, practices and barriers to implementing tuberculosis preventive treatment-35 countries, 2017","volume":"23","author":"Surie","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"issue":"March (11)","key":"10.1016\/j.ijid.2020.02.034_bib0095","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis","volume":"380","author":"Swindells","year":"2019","journal-title":"N Engl J Med"},{"issue":"December (25)","key":"10.1016\/j.ijid.2020.02.034_bib0100","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.02.034_bib0105","first-page":"6","article-title":"Report on fourth national epidemiological sampling survey of tuberculosis national technic steering group of the epidemiological sampling survey for tuberculosis","volume":"1","author":"Technical Steering Group of National Tuberculosis Epidemiological Sampling Survey","year":"2002","journal-title":"Chin J Tubere Respir Dis"},{"issue":"9979","key":"10.1016\/j.ijid.2020.02.034_bib0110","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO\u2019s new end TB strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ijid.2020.02.034_bib0115","first-page":"1121","article-title":"Guidelines on the management of latent tuberculosis infection","volume":"67","author":"WHO","year":"2015","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ijid.2020.02.034_bib0120","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1017\/S0950268816002703","article-title":"Tuberculosis infection testing in HIV-positive men who have sex with men from Xi\u2019an China","volume":"145","author":"Xin","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"June","key":"10.1016\/j.ijid.2020.02.034_bib0125","article-title":"5-year follow-up of active tuberculosis development from latent infection in rural China","author":"Xin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2020.02.034_bib0130","first-page":"505","article-title":"Interpretation of expert position paper on tuberculosis prevention and management in tumor necrosis factor antagonist application","volume":"8","author":"Xue","year":"2016","journal-title":"World Clin Drug"},{"issue":"September (9)","key":"10.1016\/j.ijid.2020.02.034_bib0135","doi-asserted-by":"crossref","first-page":"989","DOI":"10.5588\/ijtld.18.0252","article-title":"Serial T-SPOT.TBin household contacts of tuberculosis patients: a 6-year observational study in China","volume":"23","author":"Zhang","year":"2019","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220300928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220300928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:49:07Z","timestamp":1761119347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220300928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":27,"alternative-id":["S1201971220300928"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.02.034","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}